Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Mar. 31, 2019 $ 7 $ 903,803 $ (878,884) $ (1,772) $ 23,154
Balance (in shares) at Mar. 31, 2019 7,216,910     26,239  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock (in shares)       78  
Vested restricted stock awards (in shares) 229        
Stock-based compensation   262     262
Issuance of common stock, net of issuance costs $ 1 1,221     1,222
Issuance of common stock, net of issuance costs (in shares) 143,387        
Net loss     (5,593)   (5,593)
Balance at Jun. 30, 2019 $ 8 905,286 (884,477) $ (1,772) 19,045
Balance (in shares) at Jun. 30, 2019 7,360,526     26,317  
Balance at Mar. 31, 2019 $ 7 903,803 (878,884) $ (1,772) 23,154
Balance (in shares) at Mar. 31, 2019 7,216,910     26,239  
Increase (Decrease) in Stockholders' Equity          
Net loss         (14,948)
Balance at Dec. 31, 2019 $ 9 912,097 (893,907) $ (1,816) 16,383
Balance (in shares) at Dec. 31, 2019 8,841,634     36,724  
Balance at Jun. 30, 2019 $ 8 905,286 (884,477) $ (1,772) 19,045
Balance (in shares) at Jun. 30, 2019 7,360,526     26,317  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (26) (26)
Purchase of treasury stock (in shares)       3,987  
Vested restricted stock awards   26     26
Vested restricted stock awards (in shares) 1,250        
Stock-based compensation   104     104
Issuance of common stock, net of issuance costs   4,815     4,815
Issuance of common stock, net of issuance costs (in shares) 616,443        
Exercise of stock options and employee stock purchases   3     3
Exercise of stock options and employee stock purchases (in shares) 522        
Stock awards to Board of Directors   (24)     (24)
Stock awards to Board of Directors (in shares) 26,315        
Deemed dividend on purchase warrant for common shares   75 (75)    
Net loss     (4,448)   (4,448)
Balance at Sep. 30, 2019 $ 8 910,285 (889,000) $ (1,798) 19,495
Balance (in shares) at Sep. 30, 2019 8,005,056     30,304  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (18) (18)
Purchase of treasury stock (in shares)       6,420  
Vested restricted stock awards   17     17
Vested restricted stock awards (in shares) 19,961        
Stock-based compensation   303     303
Issuance of common stock, net of issuance costs   1,201     1,201
Issuance of common stock, net of issuance costs (in shares) 376,617        
Warrants exercised $ 1       1
Warrants exercised (in shares) 440,000        
Change in warrants valuation   291     291
Net loss     (4,907)   (4,907)
Balance at Dec. 31, 2019 $ 9 912,097 (893,907) $ (1,816) 16,383
Balance (in shares) at Dec. 31, 2019 8,841,634     36,724  
Balance at Mar. 31, 2020 $ 10 915,755 (900,869) $ (1,875) $ 13,021
Balance (in shares) at Mar. 31, 2020 10,286,366     57,577 10,228,789
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (4) $ (4)
Purchase of treasury stock (in shares)       3,442  
Vested restricted stock awards   4     4
Vested restricted stock awards (in shares) 16,126        
Stock-based compensation   210     210
Issuance of common stock, net of issuance costs $ 1 1,371     1,372
Issuance of common stock, net of issuance costs (in shares) 782,448        
Change in warrants valuation   99     99
Net loss     (1,823)   (1,823)
Balance at Jun. 30, 2020 $ 11 917,439 (902,692) $ (1,879) 12,879
Balance (in shares) at Jun. 30, 2020 11,084,940     61,019  
Balance at Mar. 31, 2020 $ 10 915,755 (900,869) $ (1,875) $ 13,021
Balance (in shares) at Mar. 31, 2020 10,286,366     57,577 10,228,789
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock, net of issuance costs (in shares)         782,448
Net loss         $ (13,630)
Balance at Dec. 31, 2020 $ 11 918,683 (914,514) $ (1,918) $ 2,262
Balance (in shares) at Dec. 31, 2020 11,158,647     70,422 11,088,225
Balance at Jun. 30, 2020 $ 11 917,439 (902,692) $ (1,879) $ 12,879
Balance (in shares) at Jun. 30, 2020 11,084,940     61,019  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (39) (39)
Purchase of treasury stock (in shares)       9,403  
Vested restricted stock awards   39     39
Vested restricted stock awards (in shares) 1,670        
Stock-based compensation   219     219
Stock awards to Board of Directors   (38)     (38)
Stock awards to Board of Directors (in shares) 57,098        
Deemed dividend on purchase warrant for common shares   15 (15)    
Net loss     (4,212)   (4,212)
Balance at Sep. 30, 2020 $ 11 917,674 (906,919) $ (1,918) 8,848
Balance (in shares) at Sep. 30, 2020 11,143,708     70,422  
Increase (Decrease) in Stockholders' Equity          
Vested restricted stock awards (in shares) 14,939        
Stock-based compensation   249     249
Warrants issued   760     760
Net loss     (7,595)   (7,595)
Balance at Dec. 31, 2020 $ 11 $ 918,683 $ (914,514) $ (1,918) $ 2,262
Balance (in shares) at Dec. 31, 2020 11,158,647     70,422 11,088,225